PMC:7309518 / 971-1759 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":170,"end":181},"obj":"Body_part"},{"id":"T5","span":{"begin":263,"end":270},"obj":"Body_part"},{"id":"T6","span":{"begin":308,"end":321},"obj":"Body_part"},{"id":"T7","span":{"begin":326,"end":330},"obj":"Body_part"},{"id":"T8","span":{"begin":439,"end":451},"obj":"Body_part"},{"id":"T9","span":{"begin":456,"end":472},"obj":"Body_part"},{"id":"T10","span":{"begin":473,"end":484},"obj":"Body_part"},{"id":"T11","span":{"begin":626,"end":632},"obj":"Body_part"},{"id":"T12","span":{"begin":752,"end":761},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma65239"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma82780"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma32558"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma79876"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":467,"end":472},"obj":"Body_part"},{"id":"T3","span":{"begin":752,"end":761},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002298"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":16,"end":24},"obj":"Disease"},{"id":"T23","span":{"begin":26,"end":33},"obj":"Disease"},{"id":"T24","span":{"begin":50,"end":70},"obj":"Disease"},{"id":"T25","span":{"begin":75,"end":90},"obj":"Disease"},{"id":"T26","span":{"begin":146,"end":168},"obj":"Disease"},{"id":"T27","span":{"begin":248,"end":256},"obj":"Disease"},{"id":"T28","span":{"begin":385,"end":395},"obj":"Disease"},{"id":"T29","span":{"begin":422,"end":430},"obj":"Disease"},{"id":"T30","span":{"begin":557,"end":565},"obj":"Disease"},{"id":"T31","span":{"begin":677,"end":685},"obj":"Disease"},{"id":"T32","span":{"begin":696,"end":699},"obj":"Disease"},{"id":"T34","span":{"begin":762,"end":774},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0003569"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0009722"},{"id":"A33","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0016098"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":326,"end":330},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T4","span":{"begin":456,"end":472},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"},{"id":"T5","span":{"begin":626,"end":632},"obj":"http://purl.obolibrary.org/obo/UBERON_0001630"},{"id":"T6","span":{"begin":626,"end":632},"obj":"http://purl.obolibrary.org/obo/UBERON_0005090"},{"id":"T7","span":{"begin":626,"end":632},"obj":"http://www.ebi.ac.uk/efo/EFO_0000801"},{"id":"T8","span":{"begin":626,"end":632},"obj":"http://www.ebi.ac.uk/efo/EFO_0001949"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":170,"end":181},"obj":"Chemical"},{"id":"T4","span":{"begin":201,"end":205},"obj":"Chemical"},{"id":"T5","span":{"begin":263,"end":270},"obj":"Chemical"},{"id":"T6","span":{"begin":285,"end":296},"obj":"Chemical"},{"id":"T7","span":{"begin":292,"end":296},"obj":"Chemical"},{"id":"T8","span":{"begin":308,"end":321},"obj":"Chemical"},{"id":"T9","span":{"begin":346,"end":350},"obj":"Chemical"},{"id":"T10","span":{"begin":439,"end":451},"obj":"Chemical"},{"id":"T11","span":{"begin":473,"end":484},"obj":"Chemical"},{"id":"T12","span":{"begin":509,"end":517},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_33563"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PubTator","denotations":[{"id":"49","span":{"begin":509,"end":524},"obj":"Gene"},{"id":"51","span":{"begin":99,"end":104},"obj":"Species"},{"id":"52","span":{"begin":575,"end":583},"obj":"Species"},{"id":"53","span":{"begin":594,"end":602},"obj":"Species"},{"id":"54","span":{"begin":170,"end":181},"obj":"Chemical"},{"id":"55","span":{"begin":285,"end":296},"obj":"Chemical"},{"id":"56","span":{"begin":439,"end":451},"obj":"Chemical"},{"id":"57","span":{"begin":473,"end":484},"obj":"Chemical"},{"id":"64","span":{"begin":16,"end":24},"obj":"Disease"},{"id":"65","span":{"begin":35,"end":42},"obj":"Disease"},{"id":"66","span":{"begin":50,"end":70},"obj":"Disease"},{"id":"67","span":{"begin":75,"end":90},"obj":"Disease"},{"id":"68","span":{"begin":146,"end":168},"obj":"Disease"},{"id":"69","span":{"begin":248,"end":256},"obj":"Disease"},{"id":"70","span":{"begin":378,"end":395},"obj":"Disease"},{"id":"71","span":{"begin":422,"end":430},"obj":"Disease"},{"id":"72","span":{"begin":557,"end":574},"obj":"Disease"},{"id":"73","span":{"begin":618,"end":641},"obj":"Disease"},{"id":"74","span":{"begin":677,"end":685},"obj":"Disease"},{"id":"75","span":{"begin":762,"end":774},"obj":"Disease"}],"attributes":[{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"Gene:51727"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:34205"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Tax:9606"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Tax:9606"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D005732"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D019158"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D005732"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D006017"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:C000657245"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D000370"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D003389"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D008231"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D019846"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D001039"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C000657245"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:C000657245"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D018908"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:C000657245"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D004660"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":26,"end":142},"obj":"Sentence"},{"id":"T13","span":{"begin":143,"end":499},"obj":"Sentence"},{"id":"T14","span":{"begin":500,"end":724},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":201,"end":205},"obj":"GlycoEpitope"},{"id":"T2","span":{"begin":341,"end":350},"obj":"GlycoEpitope"},{"id":"T3","span":{"begin":346,"end":350},"obj":"GlycoEpitope"}],"attributes":[{"id":"A1","pred":"glyco_epitope_db_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0059"},{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/AN0403"},{"id":"A3","pred":"glyco_epitope_db_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0059"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":26,"end":33},"obj":"Phenotype"},{"id":"T9","span":{"begin":35,"end":42},"obj":"Phenotype"},{"id":"T10","span":{"begin":75,"end":90},"obj":"Phenotype"},{"id":"T11","span":{"begin":385,"end":395},"obj":"Phenotype"},{"id":"T12","span":{"begin":500,"end":524},"obj":"Phenotype"},{"id":"T13","span":{"begin":626,"end":641},"obj":"Phenotype"},{"id":"T14","span":{"begin":762,"end":774},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0041051"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0003236"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001324"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"anifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated Creatine Kinase (\u003e10,000) is reported in 10% of COVID-19–infected patients; two such patients presented with painful muscle weakness responding to IVIg indicating that COVID-19–triggered NAM is an overlooked entity. Cases of acute necrotizing brainstem encephalitis, cranial neur"}